USE
- Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
- Allelic series of genomic modifications in cells
- Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
- Animal model for engraftment, proliferation and differentiation of human hematopoietic stem cells
- Arenavirus receptor and methods of use
- Bacterial cell component-unresponsive model mouse
- Basolateral sorting signal and inhibitors thereof
- Cap-independent multicistronic retroviral vectors
- CD45 disrupted nucleic acid
- Cell compositions for use in transplantation
- Cells and methods for the generation of transgenic pigs
- Chimeric chains for receptor-associated signal transduction pathways
- Composition and method for treating graft-versus-host disease
- Compositions and methods for non-targeted activation of endogenous genes
- Compositions and methods for non-targeted activation of endogenous genes
- Compound screening assays using a transgenic mouse model of human skin diseases
- Compounds useful for the treatment of cancer, compositions thereof and methods therewith
- construction of gene targeting using phage-plasmid recombination
- Costimulatory blockade and mixed chimerism in allo-transplantation
- Delivery of therapeutic biologicals from implantable tissue matrices
- Dual resonance energy transfer nucleic acid probes
- Efficient construction of gene targeting vectors
- Efficient method for production of compound transgenic animals
- Enhanced virus-mediated DNA transfer
- Erythropoietin-inducible, erythroid-specific DNA construct
- Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
- Gene trap construct for identification and isolation of genes
- Gene trap vectors
- Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring
- Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
- Generation of xenogeneic antibodies
- Generation of Xenogenetic antibodies
- Genetic engineering of cells to enhance healing and tissue regeneration
- Genetic modification of C57 mice
- Genetically engineered mammals for use as organ donors
- Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
- Hematopoietic cell composition for use in transplantation
- Hematopoietic cell method for treatment of HIV infection
- Hematopoietic cell method for treatment of HIV infection
- High efficiency gene trap selection of regulated genetic loci
- High throughput gene inactivation with large scale gene targeting
- HIV-MSCV hybrid viral vector for gene transfer
- Human antibodies derived from immunized xenomice
- Human antibodies derived from immunized xenomice
- Human antibodies derived from immunized xenomice
- Human antibodies derived from immunized xenomice
- Human gene/protein involved in chronic myelogenous leukemia
- In vivo production and delivery of erythropoietin
- In vivo production and delivery of erythropoietin for gene therapy
- In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy
- In vivo protein production and delivery system for gene therapy
- In vivo protein production and delivery system for gene therapy
- In vivo screening methods using enriched neural stem cells
- Induced tolerance to xenografts
- Inhibition of HIV replication using a mutated transfer RNA primer
- Interleukin-2 receptor deficient mammals
- Knockout mouse for the tumor suppressor gene ANX7
- Ku deficient cells and non-human transgenic animals
- Lineage restricted glial precursors from the central nervous system
- Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight
- Mesenchymal stem cells for cartilage repair
- Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
- Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
- Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
- Method of cloning animals
- Method of cloning porcine animals
- Method of cloning porcine animals
- Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation
- Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
- Method of producing a polypeptide in an ungulate
- Method of producing clonal cell strains which express exogenous DNA encoding glucagon-like peptide 1
- Method of producing mutant mice
- Methods and compositions for preparing a genomic library for knockout targeting vectors
- Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
- Methods and vector constructs for making non-human animals which ubiquitously express a heterologous gene
- Methods comprising apoptosis inhibitors for the generation of transgenic pigs
- Methods for diagnosis and treatment of Bloom’s syndrome
- Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
- Methods of screening biological agents
- Methods of using Flt-3 ligand for exogenous gene transfer
- Mice and cells with a homozygous disruption in the RNase L gene and methods therefore
- Mouse with defective endotheline-1 gene function
- Multipotent neural stem cell cDNA libraries
- Muri protein from Streptococcus pneumoniae
- Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)
- Nuclear targeted peptide nucleic acid oligomer
- Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
- Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
- Process for detecting potential carcinogens
- Production of proteins using homologous recombination
- Retroviral gene therapy vectors and therapeutic methods based thereon
- Sequence alterations using homologous recombination
- Site-specific recombination in eukaryotes and constructs useful therefor
- Specific tolerance in transplantation
- Stress-regulated genes of plants, transgenic plants containing same, and methods of use
- Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
- Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production
- Tetracycline-regulated transcriptional inhibitors
- Therapeutic and diagnostic compounds, compositions, and methods
- Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
- Transformed eukaryotic cells
- Transgenic knockout animals lacking IgG3
- Transgenic mice comprising CD45 knockout
- Transgenic mice containing intestinal alkaline phosphatase gene disruptions
- Transgenic mice exhibiting increased susceptibility to seizures
- Transgenic mouse expressing non-native wild-type and familial Alzheimer’s Disease mutant presenilin 1 protein on native presenilin
- Transgenic mouse for screening therapeutic agents for brain tumors
- Transgenic non-human animals capable of producing heterologous antibodies
- Transgenic non-human animals depleted in a mature lymphocytic cell-type
- Transgenic non-human animals for producing heterologous antibodies
- Transgenic rats containing at least one human gene which participates in blood pressure control
- Transgenic transchromosomal rodents for making human
- Transgenic UCP2 knockout mouse and use thereof
- Transgenic ungulate compositions and methods
- Use of human embryonic stem cells for drug screening and toxicity testing
- Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
- Uses for non-autologous mesenchymal stem cells
- Uses for non-autologous mesenchymal stem cells
- Vectors and methods for the mutagenesis of mammalian genes
- Vectors for gene mutagenesis and gene discovery
- Vivo protein production and delivery system for gene therapy
- Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
- Yeast artificial chromosomes and their use in the control of gene expression